HARVARD BIOSCIENCE, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
HARVARD BIOSCIENCE, INC. (HBIO) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $1.28 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-11
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.28M.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.43M.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.60M.
- 2025-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.77M; Lessee, Operating Lease, Liability, Undiscounted Excess Amount as first filed $1.81M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount as first filed |
|---|---|---|
| 2026-06-30 | $1.28M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $1.43M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $1.60M 10-K · filed 2026-03-13 | |
| 2025-06-30 | $1.77M 10-Q · filed 2025-11-06 | $1.81M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $1.98M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $2.00M 10-K · filed 2025-03-14 | |
| 2024-09-30 | $2.18M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $1.77M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.84M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $1.98M 10-K · filed 2024-03-07 | |
| 2023-09-30 | $2.13M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $2.28M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $2.43M 10-Q · filed 2023-04-26 | |
| 2022-12-31 | $2.60M 10-K · filed 2023-03-09 | |
| 2022-09-30 | $2.77M 10-Q · filed 2022-11-09 | |
| 2022-03-31 | $2.87M 10-Q · filed 2022-08-04 | $3.07M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $3.27M 10-K · filed 2022-03-11 | |
| 2021-09-30 | $3.46M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $3.65M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $3.85M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $4.08M 10-K/A · filed 2021-03-17 | |
| 2020-09-30 | $4.29M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $4.50M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $4.65M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $4.89M 10-K · filed 2020-03-16 | |
| 2019-09-30 | $5.12M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $5.39M 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |